StocksFin Logo
Roivant Sciences Ltd. country of incorporation
|
|
863 employees
NASDAQ | Healthcare | Biotechnology
Neogen Corporation country of incorporation
|
|
Mr. John Adent
|
2,108 employees
NASDAQ | Healthcare | Diagnostics & Research
Q223 reported Nov 14, 2022 Reporting Period
$12.53M -10.4% vs. Q222 Revenues Q223
70.95% 30.5% vs. Q222 Gross Profit Margin
-1000% ! 0% vs. Q222 Net Profit Margin
-452.27M ! -275% vs. Q222 Free Cash Flow Q223
$-0.42 ! -38% vs. Q222 EPS Q223
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q223
Q123
Q123 reported Sep 30, 2022 Reporting Period
$132.35M 3.2% vs. Q122 Revenues Q123
47.05% 0.6% vs. Q122 Gross Profit Margin
3.94% -70.4% vs. Q122 Net Profit Margin
-27.14M ! -216.9% vs. Q122 Free Cash Flow Q123
$0.05 -68.5% vs. Q122 EPS Q123
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q223
Q123
Loading...
Loading...
Ratios
As of
Dec 31, 2022
Nov 30, 2022
Quick Ratio
6.25
2.75
Current Ratio
6.74
4.22
Cash Ratio
6.25
0.66
Price to Book
5.96
1.15
Price to Sales
100
15.56
Price to Earnings
-4.05
-21.39